| 2773 |
2066: Altered Signaling |
2067: Altered, Nitric Oxide Levels |
Sep 28, 2022 |
Mar 21, 2023 |
None
|
| 2775 |
2066: Altered Signaling |
2068: Increase, Endothelial Dysfunction |
Sep 28, 2022 |
Mar 21, 2023 |
None
|
| 2840 |
2066: Altered Signaling |
2098: Abnormal Neural Remodeling |
Jan 25, 2023 |
Mar 21, 2023 |
None
|
| 2843 |
2066: Altered Signaling |
2089: Altered Bone Cell Homeostasis |
Jan 25, 2023 |
Mar 22, 2023 |
None
|
| 3400 |
2066: Altered Signaling |
1924: Increased,Cardiac fibrosis |
Nov 20, 2024 |
Nov 20, 2024 |
1 AOP
|
| 3317 |
2244: Altered Stress Response Signaling |
2067: Altered, Nitric Oxide Levels |
Jul 24, 2024 |
Aug 26, 2024 |
1 AOP
|
| 3318 |
2244: Altered Stress Response Signaling |
2068: Increase, Endothelial Dysfunction |
Jul 24, 2024 |
Aug 26, 2024 |
1 AOP
|
| 3321 |
2244: Altered Stress Response Signaling |
2098: Abnormal Neural Remodeling |
Jul 24, 2024 |
Jul 25, 2024 |
1 AOP
|
| 702 |
698: Altered, Action Potential |
699: Increased, cardiac arrthymia |
Nov 29, 2016 |
Dec 3, 2016 |
1 AOP
|
| 3407 |
698: Altered, Action Potential |
1962: Prolongation of QT interval |
Nov 20, 2024 |
Nov 20, 2024 |
1 AOP
|
| 3415 |
698: Altered, Action Potential |
1532: Decrease, Cardiac contractility |
Nov 21, 2024 |
Nov 21, 2024 |
1 AOP
|
| 3432 |
698: Altered, Action Potential |
2280: Prolonged atrioventricular (AV) |
Nov 22, 2024 |
Nov 22, 2024 |
1 AOP
|
| 1310 |
1243: Altered, Ca2+-calmodulin activated signal transduction |
341: Impairment, Learning and memory |
Nov 29, 2016 |
Dec 3, 2016 |
4 AOPs
|
| 977 |
317: Altered, Cardiovascular development/function |
358: Increase, Pericardial edema |
Nov 29, 2016 |
Jun 9, 2017 |
None
|
| 1352 |
317: Altered, Cardiovascular development/function |
350: Increase, Mortality |
Feb 9, 2017 |
Feb 9, 2017 |
None
|
| 1567 |
317: Altered, Cardiovascular development/function |
947: Increase, Early Life Stage Mortality |
Jun 9, 2017 |
Mar 23, 2018 |
3 AOPs
|
| 3189 |
2115: Cholesterol metabolism |
2223: Reduced number of oligodendrocytes |
Apr 12, 2024 |
Apr 12, 2024 |
1 AOP
|
| 3196 |
2115: Cholesterol metabolism |
2221: LXR activity, altered |
Apr 12, 2024 |
Apr 12, 2024 |
1 AOP
|
| 723 |
723: Altered, Chromosome number |
728: Increase, Aneuploid offspring |
Nov 29, 2016 |
Dec 13, 2019 |
1 AOP
|
| 1298 |
1239: Altered, Gene Expression |
1240: Altered, Protein Production |
Nov 29, 2016 |
Dec 3, 2016 |
1 AOP
|
| 1807 |
1239: Altered, Gene Expression |
1560: Cell differentiation, altered |
Dec 20, 2018 |
Dec 20, 2018 |
1 AOP
|
| 2468 |
1930: Altered, inner ear development |
1008: Reduced, Hearing |
Aug 23, 2021 |
Aug 23, 2021 |
1 AOP
|
| 738 |
752: Altered, Meiotic chromosome dynamics |
723: Altered, Chromosome number |
Nov 29, 2016 |
Dec 13, 2019 |
1 AOP
|
| 2383 |
752: Altered, Meiotic chromosome dynamics |
1775: Increase, Oocyte apoptosis |
May 12, 2021 |
May 12, 2021 |
1 AOP
|
| 2384 |
752: Altered, Meiotic chromosome dynamics |
1798: Decreased spermatogenesis |
May 12, 2021 |
May 12, 2021 |
1 AOP
|